Road Biology Environmental Protection Technology Co., Ltd. (SHA:688156)
China · Delayed Price · Currency is CNY 22.02
-0.67 (-2.95%)
At close: Sep 4, 2026
SHA:688156 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 403.13 | 363.96 | 260.19 | 341.44 | 340.34 | 380.34 |
Other Revenue | 40.14 | 16.25 | 17.42 | 9.63 | 1.74 | 1.66 |
| 443.27 | 380.21 | 277.62 | 351.08 | 342.08 | 382 | |
Revenue Growth | 58.77% | 36.95% | -20.92% | 2.63% | -10.45% | 52.56% |
Cost of Revenue | 334.77 | 308.25 | 218.66 | 224.19 | 222.82 | 240.75 |
Gross Profit | 108.5 | 71.95 | 58.96 | 126.88 | 119.26 | 141.25 |
Selling, General & Admin | 81.73 | 78.43 | 74.4 | 51.21 | 45.23 | 39.51 |
Research & Development | 13.44 | 14.67 | 19.76 | 13.65 | 13.51 | 15.95 |
Other Operating Expenses | 9.4 | 8.45 | 4.4 | 3.53 | 2.03 | 1.75 |
Operating Expenses | 122.75 | 131.29 | 130.73 | 95.42 | 77.34 | 64.39 |
Operating Income | -14.26 | -59.33 | -71.77 | 31.46 | 41.92 | 76.86 |
Interest Expense | -27.28 | -22.56 | -11.73 | -6.79 | -2.14 | -1.38 |
Interest & Investment Income | 0.94 | 1.01 | 2.84 | 5.48 | 9.25 | 8.19 |
Currency Exchange Gain (Loss) | 0.01 | 0.01 | - | - | - | - |
Other Non Operating Income (Expenses) | 0.98 | 0.51 | -1.2 | -0.27 | -0.36 | -0.44 |
EBT Excluding Unusual Items | -39.6 | -80.37 | -81.87 | 29.88 | 48.67 | 83.23 |
Gain (Loss) on Sale of Investments | - | - | - | 0.03 | 0.21 | 0.1 |
Gain (Loss) on Sale of Assets | -0.88 | -0.15 | 0.1 | -0 | 0.54 | 1.09 |
Asset Writedown | -0.02 | -0.02 | -0.07 | -0.15 | - | - |
Other Unusual Items | 3.14 | 3.01 | 3.03 | 4.1 | 0.46 | 5.24 |
Pretax Income | -37.36 | -77.53 | -78.8 | 33.85 | 49.88 | 89.67 |
Income Tax Expense | 10.87 | -7.6 | -11.8 | 4.23 | 10.67 | 10.34 |
Earnings From Continuing Operations | -48.23 | -69.93 | -67 | 29.63 | 39.21 | 79.33 |
Minority Interest in Earnings | 0.13 | -0.17 | 10.45 | -2.66 | -13.28 | -3.79 |
Net Income | -48.1 | -70.1 | -56.55 | 26.97 | 25.93 | 75.54 |
Net Income to Common | -48.1 | -70.1 | -56.55 | 26.97 | 25.93 | 75.54 |
Net Income Growth | - | - | - | 4.02% | -65.68% | 58.23% |
Shares Outstanding (Basic) | 100 | 100 | 101 | 96 | 93 | 92 |
Shares Outstanding (Diluted) | 100 | 100 | 101 | 96 | 93 | 92 |
Shares Change | -0.70% | -0.83% | 4.84% | 4.02% | 0.51% | 23.49% |
EPS (Basic) | -0.48 | -0.70 | -0.56 | 0.28 | 0.28 | 0.82 |
EPS (Diluted) | -0.48 | -0.70 | -0.56 | 0.28 | 0.28 | 0.82 |
EPS Growth | - | - | - | 0% | -65.85% | 28.13% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -100.42 | -139.78 | -287.95 | -341.8 | -145.72 | -14.48 |
Free Cash Flow Per Share | -1.00 | -1.40 | -2.85 | -3.55 | -1.57 | -0.16 |
Dividend Per Share | - | - | - | 0.050 | 0.100 | 0.300 |
Dividend Growth | - | - | - | -50.00% | -66.67% | 50.00% |
Gross Margin | 24.48% | 18.93% | 21.24% | 36.14% | 34.86% | 36.98% |
Operating Margin | -3.22% | -15.60% | -25.85% | 8.96% | 12.25% | 20.12% |
Profit Margin | -10.85% | -18.44% | -20.37% | 7.68% | 7.58% | 19.78% |
Free Cash Flow Margin | -22.65% | -36.77% | -103.72% | -97.36% | -42.60% | -3.79% |
EBITDA | 60.14 | 13.65 | -25.94 | 66.5 | 68.29 | 101.79 |
EBITDA Margin | 13.57% | 3.59% | -9.34% | 18.94% | 19.96% | 26.65% |
D&A For EBITDA | 74.4 | 72.98 | 45.83 | 35.04 | 26.37 | 24.94 |
EBIT | -14.26 | -59.33 | -71.77 | 31.46 | 41.92 | 76.86 |
EBIT Margin | -3.22% | -15.60% | -25.85% | 8.96% | 12.25% | 20.12% |
Effective Tax Rate | - | - | - | 12.49% | 21.39% | 11.53% |
Revenue as Reported | 443.27 | 380.21 | 277.62 | 351.08 | 342.08 | 382 |